deltatrials

Parkinson's disease Trials in Philadelphia, United States

Conditions / Parkinson's disease / Philadelphia, United States

Research into Parkinson's disease spans multiple therapeutic approaches and trial phases.

51 total trials for this combination

Showing top 10 of 51 trials

Trials

NCT ID Title Status Phase
NCT05543252 An Extension Study to Evaluate the Long-Term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's Disease TERMINATED PHASE2
NCT03318523 Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease TERMINATED PHASE2
NCT00099268 Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy COMPLETED PHASE3
NCT00056524 Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter) COMPLETED PHASE3
NCT00363727 Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's COMPLETED PHASE3
NCT05819359 Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD ACTIVE_NOT_RECRUITING PHASE2
NCT01060878 Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD) COMPLETED PHASE2
NCT00368108 Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations COMPLETED PHASE3
NCT02642393 Study of Urate Elevation in Parkinson's Disease, Phase 3 COMPLETED PHASE3
NCT00632736 An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease COMPLETED PHASE3

Related Pages